Last reviewed · How we verify
NCT05461144
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
trial in Metabolic Disease in 30 participants. Not yet recruiting.
1 May 2026
Quick facts
| Lead sponsor | University Hospitals Coventry and Warwickshire NHS Trust |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 30 September 2022 |
| Primary completion | 1 May 2026 |
| Estimated completion | 1 May 2027 |
Conditions studied
- Metabolic Disease — all drugs for Metabolic Disease →
Sponsor
University Hospitals Coventry and Warwickshire NHS Trust
Who can join
18 and older, any sex, with Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This observational study aims to recruit up to thirty T1DM patients from a diabetic outpatient clinic at the University Hospital Coventry and Warwickshire for a two-phase study. The first phase involves attending an inpatient protocol for up to thirty-six hours in a calorimetry room at the Human Metabolism Research Unit under controlled conditions, followed by a phase of free-living, for up to three days, in which participants will go about their normal daily activities without restriction. Throughout the study, the participants will wear commercially available wearable sensors to measure and record physiological signals (e.g., electrocardiogram and continuous glucose monitor). Data collected will be used to develop and validate an AI model using state-of-the-art deep-learning methods for the purpose of non-invasive glycaemic event detection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development of an artificial intelligence system to identify hypoglycaemia via ECG in adults with type 1 diabetes: protocol for data collection under controlled and free-living conditions.
Cisuelo O, Stokes K, Oronti IB, Haleem MS, et al · · 2023 · cited 3× · PMID 37072364 · DOI 10.1136/bmjopen-2022-067899
Verify or expand the search:
- PubMed search for NCT05461144
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Metabolic Disease
Currently open trials in the same condition.
- NCT06575426 — A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M · Phase 1, PHASE2 · recruiting
- NCT06938386 — Pilot Haskap Metabolite Timing Project · NA · active not recruiting
- NCT06954298 — Molecular Landscape of Complex Lifestyle Modification · NA · active not recruiting
- NCT06717581 — Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older. · recruiting
- NCT06529965 — Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM · NA · recruiting
Other University Hospitals Coventry and Warwickshire NHS Trust trials
Trials by the same sponsor.
- NCT07353255 — Fibrescope vs Videolaryngoscope for Nasotracheal Intubation · NA · not yet recruiting
- NCT06937983 — Optimised Decrement Evoked Potential (DeEP) Mapping to Guide Ventricular Tachycardia (VT) Ablation in Patients With Stru · NA · recruiting
- NCT06483308 — Shortened High-dose Palliative Radiotherapy for Lung Cancer · NA · active not recruiting
- NCT07014033 — Single-use Versus Multiple-use Endoscopes in Gastroenterology · recruiting
- NCT06676943 — Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resec · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05461144 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospitals Coventry and Warwickshire NHS Trust
- Last refreshed: 15 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05461144.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing